Net profit of Par Drugs & Chemicals declined 51.98% to Rs 4.13 crore in the quarter ended September 2025 as against Rs 8.60 crore during the previous quarter ended September 2024. Sales declined 17.31% to Rs 28.66 crore in the quarter ended September 2025 as against Rs 34.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales28.6634.66 -17 OPM %21.1432.92 - PBDT6.4912.40 -48 PBT5.5511.49 -52 NP4.138.60 -52 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Par Drugs & Chemicals announced that the 26th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 29 August 2025.Powered by Capital Market - Live News

Net profit of Par Drugs & Chemicals rose 31.62% to Rs 3.33 crore in the quarter ended June 2025 as against Rs 2.53 crore during the previous quarter ended June 2024. Sales rose 15.21% to Rs 26.05 crore in the quarter ended June 2025 as against Rs 22.61 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales26.0522.61 15 OPM %13.6718.71 - PBDT5.384.28 26 PBT4.483.38 33 NP3.332.53 32 Powered by Capital Market - Live News